Profile data is unavailable for this security.
About the company
CoDon AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company develops, produces, and distributes autologous cell therapies for the minimally invasive repair of cartilage defects, it manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures, and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. It also offers biopsy, cultivation, transplantation, rehabilitation and others.
- Revenue in EUR (TTM)9.84m
- Net income in EUR-14.13m
- Incorporated1999
- Employees134.00
- LocationCoDon AGWarthestrasse 21TELTOW 14513GermanyDEU
- Phone+49 332843460
- Fax+49 3 328434643
- Websitehttps://www.codon.de/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lipigon Pharmaceuticals AB | 123.00k | -3.36m | 316.91k | 7.00 | -- | 0.2249 | -- | 2.58 | -0.1317 | -0.1317 | 0.0035 | 0.0249 | 0.0674 | -- | 0.2937 | 188,142.90 | -183.92 | -860.41 | -214.33 | -1,152.75 | -- | -- | -2,731.06 | -1,282.24 | -- | -- | 0.00 | -- | -37.30 | 42.64 | 74.22 | -- | -- | -- |
| Apollo Biowellness Inc | 1.91m | -1.71m | 394.29k | 6.00 | -- | -- | -- | 0.2065 | -0.0189 | -0.0189 | 0.02 | -0.0216 | 0.6255 | -- | -- | -- | -56.14 | -371.95 | -- | -- | 65.52 | 58.46 | -89.76 | -533.66 | -- | -5.26 | -- | -- | 11,413.18 | -- | -50.65 | -- | -- | -- |
| CoDon AG | 9.84m | -14.13m | 405.17k | 134.00 | -- | 0.0628 | -- | 0.0412 | -0.5513 | -0.5513 | 0.4018 | 0.2468 | 0.5161 | 0.9864 | 10.10 | 73,432.84 | -74.08 | -41.86 | -86.85 | -48.53 | 94.10 | 91.39 | -143.53 | -139.57 | 0.8393 | -21.92 | 0.4887 | -- | 57.28 | 11.86 | 32.79 | -- | 24.07 | -- |
| Aequus Pharmaceuticals Inc | 574.55k | -410.58k | 414.85k | 12.00 | -- | -- | -- | 0.722 | -0.005 | -0.005 | 0.0069 | -0.052 | 1.74 | 7.59 | 7.95 | -- | -124.52 | -97.48 | -- | -- | 56.95 | -- | -71.46 | -148.91 | 0.027 | -2.08 | -- | -- | 129.20 | -18.58 | 26.55 | -- | -- | -- |
| Altamira Therapeutics Ltd | 0.00 | -4.84m | 488.98k | 13.00 | -- | 0.1403 | -- | -- | -1.45 | -1.45 | 0.00 | 0.7128 | 0.00 | -- | -- | 0.00 | -74.38 | -74.95 | -96.95 | -118.32 | -- | -- | -- | -- | -- | -- | 0.1624 | -- | -- | -- | -4.53 | -- | -49.17 | -- |
| Grapefruit USA Inc | 29.82k | -3.74m | 497.04k | 9.00 | -- | -- | -- | 16.67 | -0.008 | -0.008 | 0.00006 | -0.0101 | 0.0121 | 1.31 | 0.2259 | 3,872.22 | -151.85 | -268.93 | -- | -- | -1,304.65 | -10.09 | -12,531.68 | -408.87 | 0.0388 | -1.50 | -- | -- | -83.96 | 77.87 | -35.68 | -- | -- | -- |
| Neutra Corp | 56.53k | -152.14k | 520.67k | -- | -- | -- | -- | 9.21 | -0.00006 | -0.00006 | 0.00002 | -0.0003 | 2.42 | -- | -- | -- | -652.23 | -401.90 | -- | -- | 64.32 | -- | -269.11 | -1,234.68 | -- | -38.69 | -- | -- | -41.87 | -- | 59.53 | -- | -- | -- |
| Lumiera Health Inc | 370.69k | -1.48m | 528.64k | -- | -- | -- | -- | 1.43 | -0.0139 | -0.0139 | 0.0035 | -0.0136 | 0.5096 | 2.13 | 11.78 | -- | -202.92 | -- | -- | -- | 13.17 | -- | -398.18 | -- | 0.0395 | -2.10 | -- | -- | 46.91 | -- | -188.58 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Aramea Asset Management AGas of 30 Jun 2022 | 0.00 | 0.00% |
